zaprinast and 1-3-dipropyl-8-cyclopentylxanthine

zaprinast has been researched along with 1-3-dipropyl-8-cyclopentylxanthine* in 1 studies

Other Studies

1 other study(ies) available for zaprinast and 1-3-dipropyl-8-cyclopentylxanthine

Article	Year
Activation of the NO-cGMP signalling pathway depresses hippocampal synaptic transmission through an adenosine receptor-dependent mechanism. Neuropharmacology, 1994, Volume: 33, Issue:11 Activation of the NO-cGMP pathway or adenosine receptors depresses reversibly synaptic transmission in the hippocampus. Here we demonstrate, using the selective A1 receptor antagonist DPCPX, a convergence in the mechanisms of action of the NO donor SNAP, the cGMP phosphodiesterase inhibitor zaprinast and adenosine. Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic GMP; Hippocampus; In Vitro Techniques; Neural Pathways; Nitric Oxide; Penicillamine; Purinergic P1 Receptor Antagonists; Purinones; Rats; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Synapses; Synaptic Transmission; Vasodilator Agents; Xanthines	1994

Article

Year

Activation of the NO-cGMP signalling pathway depresses hippocampal synaptic transmission through an adenosine receptor-dependent mechanism.

Neuropharmacology, 1994, Volume: 33, Issue:11

Activation of the NO-cGMP pathway or adenosine receptors depresses reversibly synaptic transmission in the hippocampus. Here we demonstrate, using the selective A1 receptor antagonist DPCPX, a convergence in the mechanisms of action of the NO donor SNAP, the cGMP phosphodiesterase inhibitor zaprinast and adenosine.

Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic GMP; Hippocampus; In Vitro Techniques; Neural Pathways; Nitric Oxide; Penicillamine; Purinergic P1 Receptor Antagonists; Purinones; Rats; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Synapses; Synaptic Transmission; Vasodilator Agents; Xanthines

1994